SYRA vs LIMN
Comparison between Syra Health Corp - Class A (SYRA, Company) and Liminatus Pharma Inc (LIMN, Company).
Both SYRA and LIMN are from the Healthcare sector.
SYRA vs LIMN - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
SYRA
$5.37M
LIMN
$5.35M
Max Drawdown
Winner
SYRA
98.93%
LIMN
99.57%
Sharpe Ratio
Winner
SYRA
1.76
LIMN
-1.35
Industry
SYRA
Medical Care Facilities
LIMN
Biotechnology
P/E Ratio
Winner
SYRA
-10.04
LIMN
-0.31
Debt to Equity
SYRA
0.00%
Winner
LIMN
-1087.89%
Free Cash Flow Yield
SYRA
14.07%
LIMN
N/A
SYRA vs LIMN - Historical Returns
Returns include dividend reinvestment.
1M
Winner
SYRA
+12.47%
LIMN
-36.29%
3M
Winner
SYRA
+139.31%
LIMN
-43.83%
6M
Winner
SYRA
+399.89%
LIMN
-85.28%
1Y
Winner
SYRA
+345.89%
LIMN
-99.07%
Max(CAGR)
Winner
SYRA
-50.24%
LIMN
-98.02%
SYRA vs LIMN - Annual Returns (2023 - 2026)
Returns include dividend reinvestment.
| Year | SYRA | LIMN |
|---|---|---|
| 2026 | +415.35% | -81.40% |
| 2025 | -80.53% | -93.94% |
| 2024 | -62.38% | N/A |
| 2023 | -66.14% | N/A |
SYRA vs LIMN Drawdown Comparison
The maximum drawdown for SYRA was -98.93%, occurring on Apr 23, 2025. This drawdown has not yet recovered.
The maximum drawdown for LIMN was -99.57%, occurring on Jun 16, 2026. This drawdown has not yet recovered.
The current SYRA drawdown is -90.72%. The current LIMN drawdown is -99.55%.
| Rank | SYRA | LIMN |
|---|---|---|
| #1 | -98.93% Feb 8, 2024 - Apr 23, 2025 | -99.57% Jun 24, 2025 - Jun 16, 2026 |
| #2 | -70.62% Oct 2, 2023 - Feb 8, 2024 | -57.27% Jun 9, 2025 - Jun 24, 2025 |
| #3 | N/A | -54.72% May 1, 2025 - Jun 4, 2025 |
| #4 | N/A | -1.54% Jun 5, 2025 - Jun 9, 2025 |
Correlation
Correlation between SYRA and LIMN is -0.37 which considered as a weak negative correlation - the stocks show a slight tendency to move in opposite directions.
-0.37
-101
Select Stocks to Compare
Popular: SYRA vs SPYLIMN vs SPY
More Comparisons
Compare with similar stocks